Schedule 13G ownership disclosure

Epizyme, Inc.

Security class unavailable · CUSIP: 29428V104

Event date: 2020-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
15,068,427
Percent of class
14.8500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-113553
Form type
SC 13G
Filer
Epizyme, Inc.
CIK
CIK 1571498
Filed
Oct 09, 2020
Reporting period
Sep 30, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub